RGGGH biochemistry lab reduces patient queues with web portal, bar code system, point-of-care testing, and therapeutic drug ...

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

A study led by UCL found that individuals with rare diseases were five times more likely to die from Covid-19 than the ...

Background Healthcare patient safety investigations inappropriately focus on individual culpability and the target of ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

Palvella Therapeutics is set to expand Phase III SELVA trial to include subjects aged three to five years old.

T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

A groundbreaking test can now predict colorectal cancer risk in IBD patients with over 90 accuracy offering a less invasive ...

The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...

What is the Patient Safety Initiative? The Patient Safety Initiative is a collaborative, data-driven effort that gives hospitals and health systems a strong voice in the national conversation around ...